Coutton C, Guigon M, Bohbot A, Ferrani K, Oberling F
Institut d'Hématologie et d'Immunologie, Hospices civils, Université Louis Pasteur, Strasbourg, France.
Exp Hematol. 1994 Oct;22(11):1076-80.
The tetrapeptide AcSDKP (Ser-Asp-Lys-Pro) is a reversible inhibitor of normal human hematopoietic progenitor growth. In this paper, we report that preincubation of bone-marrow mononuclear cells (MNC) with AcSDKP at 10(-10) M for 20 hours protects the granulocyte-macrophage colony-forming unit (CFU-GM) progenitors against photofrin II-mediated phototherapy. This protective effect was observed after short-term exposure to photofrin (2.5 micrograms/mL) and irradiation by high-energy doses at 514 nm. Nevertheless, AcSD-KP, which has no effect on leukemic cell proliferation, does not protect the HL-60 and K-562 leukemic cell lines against photosensitization.
四肽AcSDKP(丝氨酸-天冬氨酸-赖氨酸-脯氨酸)是正常人类造血祖细胞生长的可逆抑制剂。在本文中,我们报告称,用10⁻¹⁰ M的AcSDKP对骨髓单个核细胞(MNC)进行20小时的预孵育,可保护粒细胞-巨噬细胞集落形成单位(CFU-GM)祖细胞免受卟啉钠II介导的光疗影响。在短期暴露于卟啉钠(2.5微克/毫升)并以514纳米的高能量剂量照射后,观察到了这种保护作用。然而,对白血病细胞增殖无影响的AcSD-KP并不能保护HL-60和K-562白血病细胞系免受光致敏作用。